Psilocybin Anxiety Treatment: What the Research Shows
Psilocybin anxiety treatment has produced large, lasting reductions in anxiety across controlled trials, first in people facing cancer-related distress and more recently in generalized anxiety disorder....
Psychedelic Therapy for Anxiety Disorders: What the Research Shows
The strongest evidence for psychedelic therapy in anxiety disorders comes from trials treating anxiety tied to a life-threatening illness, where single doses of psilocybin or LSD...
Ketamine for Anxiety Disorders: What the Research Shows
Ketamine anxiety treatment has shown rapid, short-lived reductions in symptoms of generalized and social anxiety disorder across several small controlled trials, often within hours of a...
Psilocybin and the Aging Brain: What the Research Shows So Far
Research into psilocybin aging effects is accelerating, with preclinical studies pointing to neuroplasticity promotion, reduced neuroinflammation, and improvements in longevity biomarkers. The findings are genuinely interesting,...
Psilocybin for End-of-Life Anxiety: What the Research Shows
Research into psilocybin for end-of-life anxiety has produced some of the most compelling clinical data in psychedelic science. Landmark trials at Johns Hopkins and NYU found...
Ready to take the next step?
Start with a complimentary conversation, or take the two-minute self-evaluation to see if this is your moment.